Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Carruthers J, Carruthers A . Treatment of glebellar frown lines with C. botulinum exotoxin. J Dermatol Surg Oncol 1992; 18: 17–21.
Carruthers A, Carruthers J . Clinical indications and injection technique for the cosmetic use of botulinum-A exotoxin. Dermatol Surg 1998; 24: 1189–1194.
Foster JA, Wulc AE, Barnhorst D, Papay F . The use of botulinum A toxin to ameliorate Facial dynamic lines. Int J Aesthet Reconst Surg 1996; 4: 137–144.
Lowe NJ . Botulinum toxin type A for facial rejuvenation: US and UK perspectives. Dermatol Surg 1998; 24: 1216–1218.
Moore P . Handbook of Botulinum Toxin Treatment. 1st edn. Blackwell Science Publication: Oxford, 1999.
Horn A, Porter JD, Evinger C . Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics. Exp Brain Res 1993; 96: 39–53.
Simpson LL . Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 1980; 212: 16–21.
Putterman AM, Cosmetic Oculoplastic Surgery, Vol II, 3rd edn. WB Saunders. Philadelphia: 1999, pp 77–90.
Baylis HI, Golberg RA, Kerivan K, Jacobs J . Analysis and treatment of the ageing face. Dermatol Clin 1997; 15(4): 635–647.
Acknowledgements
Proprietary/Financial interest: None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chua, C., Gibson, A. & Rowson, N. Dermatochalasis: a potential pitfall in botulinum rejuvenation. Eye 18, 98–101 (2004). https://doi.org/10.1038/sj.eye.6700527
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6700527
